These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38797808)

  • 21. Short-term mechanical circulatory support with the Impella 5.0 device for cardiogenic shock at La Pitié-Salpêtrière.
    Mastroianni C; Bouabdallaoui N; Leprince P; Lebreton G
    Eur Heart J Acute Cardiovasc Care; 2017 Feb; 6(1):87-92. PubMed ID: 26873912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Percutaneous left ventricular assist support is associated with less pulmonary congestion and lower rate of pneumonia in patients with cardiogenic shock.
    Haberkorn S; Uwarow A; Haurand J; Jung C; Kelm M; Westenfeld R; Horn P
    Open Heart; 2020 Nov; 7(2):. PubMed ID: 33132209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Case Report: High-Calorie Glucose Infusion and Tight Glycemic Control in Ameliorating Refractory Acidosis of Empagliflozin-Induced Euglycemic Diabetic Ketoacidosis.
    Wan Azman SS; Sukor N; Abu Shamsi MY; Ismail I; Kamaruddin NA
    Front Endocrinol (Lausanne); 2022; 13():867647. PubMed ID: 35712244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Euglycemic diabetic ketoacidosis due to a strict low-carbohydrate diet during treatment with sodium-glucose cotransporter 2 inhibitors.
    Fukuyama Y; Numata K; Yoshino K; Santanda T; Funakoshi H
    Acute Med Surg; 2020; 7(1):e480. PubMed ID: 31988792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiogenic shock complicating peripartum cardiomyopathy: Importance of early left ventricular unloading and bromocriptine therapy.
    Sieweke JT; Pfeffer TJ; Berliner D; König T; Hallbaum M; Napp LC; Tongers J; Kühn C; Schmitto JD; Hilfiker-Kleiner D; Schäfer A; Bauersachs J
    Eur Heart J Acute Cardiovasc Care; 2020 Mar; 9(2):173-182. PubMed ID: 29792513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Real-life use of left ventricular circulatory support with Impella in cardiogenic shock after acute myocardial infarction: 12 years AMC experience.
    Ouweneel DM; de Brabander J; Karami M; Sjauw KD; Engström AE; Vis MM; Wykrzykowska JJ; Beijk MA; Koch KT; Baan J; de Winter RJ; Piek JJ; Lagrand WK; Cherpanath TG; Driessen AH; Cocchieri R; de Mol BA; Tijssen JG; Henriques JP
    Eur Heart J Acute Cardiovasc Care; 2019 Jun; 8(4):338-349. PubMed ID: 30403366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. On-label use of sodium-glucose cotransporter 2 inhibitors might increase the risk of diabetic ketoacidosis in patients with type 1 diabetes.
    Horii T; Oikawa Y; Atsuda K; Shimada A
    J Diabetes Investig; 2021 Sep; 12(9):1586-1593. PubMed ID: 33448127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contemporary trends in use of mechanical circulatory support in patients with acute MI and cardiogenic shock.
    Helgestad OKL; Josiassen J; Hassager C; Jensen LO; Holmvang L; Udesen NLJ; Schmidt H; Berg Ravn H; Moller JE
    Open Heart; 2020; 7(1):e001214. PubMed ID: 32201591
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Impella Microaxial Flow Catheter Is Safe and Effective for Treatment of Myocarditis Complicated by Cardiogenic Shock: An Analysis From the Global cVAD Registry.
    Annamalai SK; Esposito ML; Jorde L; Schreiber T; A Hall S; O'Neill WW; Kapur NK
    J Card Fail; 2018 Oct; 24(10):706-710. PubMed ID: 30244180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative Safety of Sodium-Glucose Cotransporter 2 Inhibitors Versus Dipeptidyl Peptidase 4 Inhibitors and Sulfonylureas on the Risk of Diabetic Ketoacidosis.
    Dawwas GK; Flory JH; Hennessy S; Leonard CE; Lewis JD
    Diabetes Care; 2022 Apr; 45(4):919-927. PubMed ID: 35147696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SGLT2 Inhibitors: A Systematic Review of Diabetic Ketoacidosis and Related Risk Factors in the Primary Literature.
    Burke KR; Schumacher CA; Harpe SE
    Pharmacotherapy; 2017 Feb; 37(2):187-194. PubMed ID: 27931088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Persistent cardiac arrest caused by profound hypokalaemia after large-dose insulin injection in a young man with type 1 diabetes mellitus: successful rescue with extracorporeal membrane oxygenation and subsequent ventricular assist device.
    Wang YH; Tsai CS; Tsai YT; Lin CY; Yang HY; Chen JL; Hsu PS
    Cardiovasc J Afr; 2020; 31(6):339-342. PubMed ID: 32628241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac sarcoidosis presenting with cardiogenic shock successfully recovered by Impella and corticosteroid pulse therapy: a case report.
    Hashimura M; Ikeda Y; Koitabashi T; Ako J
    Eur Heart J Case Rep; 2023 Feb; 7(2):ytad045. PubMed ID: 36793932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Device profile of the Impella 5.0 and 5.5 system for mechanical circulatory support for patients with cardiogenic shock: overview of its safety and efficacy.
    Pahuja M; Hernandez-Montfort J; Whitehead EH; Kawabori M; Kapur NK
    Expert Rev Med Devices; 2022 Jan; 19(1):1-10. PubMed ID: 34894975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dapagliflozin-associated euglycemic diabetic ketoacidosis in a patient with type 2 diabetes mellitus: A case report.
    Lee IH; Ahn DJ
    Medicine (Baltimore); 2020 May; 99(21):e20228. PubMed ID: 32481295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prolonged euglycemic diabetic ketoacidosis triggered by a single dose of sodium-glucose cotransporter 2 inhibitor.
    Miwa M; Nakajima M; Kaszynski RH; Goto H
    BMJ Case Rep; 2020 Oct; 13(10):. PubMed ID: 33028568
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined pulmonary and left ventricular support with veno-pulmonary ECMO and impella 5.0 for cardiogenic shock after coronary surgery.
    Sayed S; Schimmer C; Shade I; Leyh R; Aleksic I
    J Cardiothorac Surg; 2017 May; 12(1):38. PubMed ID: 28532425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impella-Induced Incessant Ventricular Tachycardia.
    Kaki A; Subahi A; Shokr M; Ibrahim W; Yassin A; Hasan R; Alraies MC; Schreiber T
    Ochsner J; 2019; 19(3):248-251. PubMed ID: 31528136
    [No Abstract]   [Full Text] [Related]  

  • 39. Can euglycemic Diabetic Ketoacidosis Caused by SGLT2 Inhibitors be avoided in Covid-19 and other acute Infections?
    Pilianidis G; Papanastasiou G; Tikoudi P; Themistocleous A; Farmakis G; Dolianitis K
    Eur J Case Rep Intern Med; 2024; 11(3):004282. PubMed ID: 38455692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. "Normal but Catastrophic" Euglycemic Diabetic Ketoacidosis Precipitated by Sodium-Glucose Cotransporter-2 Inhibitor Use: A Case Report.
    Sarno MJF; Hernandez DPF; Matulac MO
    Cureus; 2023 Nov; 15(11):e49236. PubMed ID: 38143642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.